Jeffrey L. Probstfield

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

David J. Gordon, Jeffrey L. Probstfield, Robert J. Garrison et al. · Circulation · 1989 · 3.2K citations · Full text

Medicine, Cardiology, Preventive Medicine +17

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

John W. Eikelboom, Stuart J. Connolly, Jackie Bosch et al. · New England Journal of Medicine · 2017 · 2.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers

Scott M. Lippman, Eric A. Klein, Phyllis J. Goodman et al. · JAMA · 2008 · 2.1K citations · Full text

Public Health, Nutritional Sciences, Oncology +14

Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial

Marc A. Pfeffer, Brian Claggett, Susan F. Assmann et al. · Circulation · 2014 · 1K citations

Medicine, Cardiology, Pharmacotherapy +15